The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...

The following is a summary of “Impact of Ablation on AF burden and symptoms in HCM,” published in the October 2024 issue of ...

Medtronic receives US FDA approval for Affera Mapping and Ablation System with Sphere-9 catheter: Galway, Ireland Saturday, October 26, 2024, 17:00 Hrs [IST] Medtronic plc, a glob ...

Woodland Heights Medical Center is pleased to announce treatment of its first patient with a new system that used Pulsed ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

Atrial fibrillation (AF) is one of the most common types of arrhythmia, affecting millions worldwide. As healthcare systems ...

Introduction Cardiac ablation is a medical procedure for treating arrhythmias (irregular heartbeats). Arrhythmias are electrical irregul ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...